Here are my observations. 1. The LOIs with the toxic

New Post Public Reply Private Reply Replies (2) Message Board
All Aboard
699
Here are my observations.

1. The LOIs with the toxic debt and preferred shareholders are binding.

2. The binding LOIs contain a standstill provision that prevents them from converting and selling (i.e., no more dilution).

3. All of the senior convertible debt of the company is being paid off at 80% of the principal amount only AND they are surrendering all related warrants. That is a nice discount.

4. As of the last Q, the principal amount owed on the senior convertible debt was $5,352,000. 80% of that is $4,281,600. So AMBS will have to give them 13,380,000 shares of Avant (assuming $0.16 a share) plus a new non-interest bearing note for $2,140,800.

5. Almost all of the preferred equity of the company (94%) is being paid off at 75% of the stated value AND they are surrendering all related warrants. That is a nicer discount. The stated value of the Series E and H is $1,000 a share.

6. Per the 8K, there were 8,791 shares of Series E issued and outstanding and 6,085 shares of Series H outstanding. So the stated value of the Series E and H is $14,876,000. 75% of that is $11,157,000. So AMBS will have to give them 34,865,625 shares of Avant (assuming a $0.16 a share) plus a new non-interest bearing note for $5,578,500.

8. The new notes are convertible at a minimum of $3 or $4 a share and may only be converted after AMBS up-lists to NASDAQ or the NYSE. (Doesn't say this conversion price is post-reverse split, but I assume it is.)

9. In addition, AMBS is giving 35% of the ESS subsidiary (Cutanogen) to the senior debt and preferred shareholders. However, AMBS can buy that 35% back for $50M anytime within 3 years.

10. The Series E and H no longer have the right to vote on a reverse split. And the holders of the approximately 6% of the Series E and 6% of the Series H may now only convert after AMBS up-lists at a price equal to the average price for the previous 12 days.

11. AMBS has until June 25 to do 2 out of the following 3 capital raises:

a) AMBS raises at least $1.5 million in financing;
b) Avant Diagnostics, Inc. raises at least $1.5 million in financing; or
c) Cutanogen Corporation raises at least $2.5 million in financing.

12. The investments in either AMBS or Avant must be accompanied by a fairness opinion.

13. Avant was considering a merger with PHDx Inc. but is no longer considering that merger.

14. Cutanogen will be managed by Alliqua Biomedical. That's probably the "commercial stage wound company" mentioned as a potential JV.

15. Chan Heng Fai bought voting control via the purchase of shares of Series F. Although the 8K says that such shares are not convertible (twice), if you review what was filed in Nevada, they are absolutely convertible at a conversion price of $0.03 a share.

16. AMBS now owes Memory DX 5 million shares of Avant and $75,000.

17. The Army kicked AMBS and ESS to the curb.

18. Jack Brewer is part of the group of preferred stock holdouts and is suing AMBS. Part of their request is injunctive relief - i.e., asking for a court order to put a stop to the above actions. Generally, injunctive relief is only granted when the plaintiff cannot be made whole via monetary damages.

Wow - a lot going on. This is a complex deal with a lot left to go. But given that Chan Heng Fai now controls the company, I don't see meeting the financing goals as a challenge.

We gave away most of our Avant shares, but we will get rid of almost all of the toxics at a discount.

I know some have posted that they are disappointed that we didn't get a large cash infusion. I think it is too early for that. For example, if we raised $30M while trading at $0.06 a share, we would have to issue 500 million shares. Large capital infusions can come in the future - when our shares are trading at a level that accurately reflects the value of the company.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 65

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading
Healthcare's Prevention Puzzle Needs Better Incentives

Updated Category News Views 107

When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...

Continue Reading
S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 54

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading
Branch's Fast 500 Rank Signals Payroll Platform Reach

Updated Category News Views 118

Six straight appearances on Deloitte's Fast 500 is not random confetti; it says Branch has kept finding customers while plenty of fintech outfits were busy shrinking their ambitions. The Tampa-based workforce-payments company landed at No. 146 in the 2026 ranking, which measures fiscal-year revenue growth from 2022 through 2025. That is a respectable showing in a list...

Continue Reading
GIGABYTE Pitches Local AI Agents to Enterprise Buyers

Updated Category News Views 72

Enterprise AI has reached the awkward stage where a slick chatbot demo no longer cuts it. GIGABYTE used its November 13 AI Partner Summit at the Pacific Palms Resort to make a more grounded pitch: companies need hardware and software setups that can put AI agents to work without casually tossing proprietary information into somebody else’s cloud. That is a sensible...

Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 108

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 78

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
Appian Survey Flags AI Aloneware Maintenance Drag Risk

Updated Category News Views 58

A bot can spit out a feature before lunch, then leave a repair bill nobody budgeted for. That is the uncomfortable issue behind Appian's new research on AI-assisted software development: speed is easy to celebrate, while ownership gets shoved into a dark corner until something breaks. Appian said on November 20, 2026, that two-thirds of surveyed AI decision-makers and IT...

Continue Reading

Top 5 Most Recently Viewed Articles

Bitfarms and Riot Platforms Reach Important Settlement Agreement

Updated Category News Views 57

Bitfarms Ltd and Riot Platforms Reach Settlement on Disputes Today, Bitfarms Ltd (NASDAQ:BITF), a leading player in the cryptocurrency mining field, announced that it has successfully settled disputes with Riot Platforms (NASDAQ:RIOT). This important settlement seeks to resolve various conflicts that existed between the two companies, although the specific details of...

Continue Reading
Peer To Peer Network Unveils Strategic Insights for PTOP Labs

Updated Category News Views 195

Peer To Peer Network Reveals Insights on PTOP Intelligence Labs Peer To Peer Network (OTC: PTOP) has taken a decisive step towards revolutionizing investor communication and engagement with the introduction of PTOP Intelligence Labs. During a recent call, the company’s newly appointed division president, Derek McCarthy, shared insights into the innovative AI-driven...

Continue Reading
Firsthand Technology Fund Reports Third Quarter Financial Performance

Updated Category News Views 234

Firsthand Technology Value Fund Financial Overview Firsthand Technology Value Fund, Inc. (OTCQB: SVVC), a publicly trading venture capital fund focused on technology and cleantech investments, has provided an update on its financial performance for the recent quarter. As of the end of September, the Fund reported net assets amounting to $296,547, translating to $0.04 per...

Continue Reading
Nanit Unveils Innovative AI Sleep Score Tailored for Babies

Updated Category News Views 310

Nanit Launches Groundbreaking AI Sleep Score for Infants Nanit has introduced an innovative Sleep Score feature aimed specifically at helping parents enhance their babies' sleep quality. This groundbreaking technology translates complex clinical-grade sleep data into a single, easy-to-understand number. Parents will now have access to a powerful tool that demystifies...

Continue Reading
The Surge of the Manufacturing Execution System Market

Updated Category News Views 155

Introduction to the Manufacturing Execution System Market The global manufacturing execution system (MES) market is experiencing remarkable growth, fueled by the rising trend of digital transformation across various manufacturing sectors. As industries evolve, the demand for real-time data and efficient management of production processes is becoming increasingly critical....

Continue Reading